Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
Go back to Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program| Compugen Ltd (NASDAQ: CGEN) | Delayed: 2.47 -0.03 (1.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.50 | 52 Week High | $7.79 | |||
| Open | $2.50 | 52 Week Low | $4.32 | |||
| Day High | $2.50 | P/E | N/A | |||
| Day Low | $2.46 | EPS | $-0.36 | |||
| Volume | 21,310 | |||||
